Study | Type of Study | Complications & Adverse events |
---|---|---|
Abusedera et al. 2014 | RCT | None reported. |
Duvnjak and Andersen 2020 | RCT | None reported. |
Hartnell et al. 1999 | Observational (retrospective & prospective) | None reported. |
Katsumori et al. 2020 | Observational (retrospective) | None reported. |
Keyoung et al. 2001 | RCT | Trial concluded prematurely. 7/10 of those receiving lidocaine had moderate to severe vasospasm with restricted flow for 10–20 min. |
Lee et al. 2001 | RCT | One patient had a transient (~ 10 min) decrease in blood pressure (from 120/80 mmHg to 90/60 mmHg) after lidocaine injection. |
Molgaard et al. 1990 | Observational (retrospective & prospective) | None reported. |
Noel-Lamy et al. 2017 | RCT | Statistically significant reduction (p = 0.045) in proportion of patients with complete infarction of leiomyoma in those receiving lidocaine during UFE (38.9%) (n = 18) compared to those receiving lidocaine after UFE (77.8%) (n = 18) and control group (75%) (n = 20). |
Zhan et al. 2005 | RCT | None reported |